Ginkgo Bioworks Holdings, Inc. DNA
Set alert
11.21 USD -1.53 -12.01%
At close · Oct 30
11.34 +0.13 +1.16%
After hours · Oct 30, 6:30 PM ET
10.61 Day range 12.61
5.48 52-week range 14.98
- YTD
- +34.90%
- 1 year
- -6.66%
- Open
- 12.12
- Prev close
- 12.74
- Mkt cap
- 754.88M
- Vol
- 2.73M
- Avg vol
- 2.19M
- EPS
- -5.06
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.61
- High
- 12.61
- Forward P/E
- -5.17
- Beta
- 1.79
- Short ratio
- 6.35
- Inst. own
- 73.73%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 8.08
- 200-d avg
- 8.32
- 1y target
- 7.00
MAX chart
Events in this range
- Aug 20, 2024Split: 1 for 40
- Sep 20, 2024Rating: TD Cowen · Buy → Buy
- Aug 7, 2025Earnings: -1.1; estimate -1.44; surprise 23.61%
- Aug 25, 2025Rating: BTIG · Sell → Sell
- Nov 6, 2025Earnings: -1.45; estimate -1.24; surprise -16.94%
- Jan 8, 2026Rating: TD Cowen · Buy → Buy
- Feb 26, 2026Earnings: -1.42; estimate -1.8; surprise 21.11%
- Mar 12, 2026Rating: BTIG · Sell → Sell
- May 7, 2026Earnings: -1.39; estimate -1.21115; surprise -14.77%
- Aug 5, 2026Earnings: -0.75; estimate -0.895; surprise 16.2%
- Aug 7, 2026Downgrade: TD Cowen · Buy → Hold
- Sep 4, 2026Rating: BTIG · Sell → Sell
- Nov 5, 2026Earnings: —; estimate -0.58; surprise —%
Signals (95)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 3, 2026 | 2 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 23, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 9 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| MACD: Sell Signal | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 5, 2025 | 1 year ago |
| SMA: Bearish | Apr 28, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 14, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 24, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| SMA: Bearish | Feb 17, 2025 | 1 year ago |
| SMA: Bullish | Dec 30, 2024 | 1 year ago |
| SMA: Bullish | Nov 25, 2024 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bullish | Oct 14, 2024 | 2 years ago |
| RSI: Oversold | Oct 7, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 19, 2024 | 2 years ago |
| RSI: Oversold | Jul 29, 2024 | 2 years ago |
| RSI: Oversold | May 27, 2024 | 2 years ago |
| SMA: Bearish | Feb 19, 2024 | 2 years ago |
| SMA: Bullish | Feb 12, 2024 | 2 years ago |
| SMA: Bearish | Jan 8, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 8, 2024 | 2 years ago |
| MACD: Buy Signal | Dec 18, 2023 | 2 years ago |
| SMA: Bullish | Dec 11, 2023 | 2 years ago |
| SMA: Bearish | Oct 9, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 25, 2023 | 3 years ago |
| SMA: Bearish | Sep 11, 2023 | 3 years ago |
| SMA: Bullish | Aug 28, 2023 | 3 years ago |
| SMA: Bullish | Aug 21, 2023 | 3 years ago |
| SMA: Bearish | Aug 14, 2023 | 3 years ago |
| SMA: Bearish | Aug 7, 2023 | 3 years ago |
| SMA: Bullish | May 29, 2023 | 3 years ago |
| SMA: Bullish | May 22, 2023 | 3 years ago |
| SMA: Bearish | Feb 6, 2023 | 3 years ago |
| SMA: Bullish | Jan 23, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 16, 2023 | 3 years ago |
| MACD: Sell Signal | Dec 5, 2022 | 3 years ago |
| SMA: Bearish | Nov 14, 2022 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| SMA: Bearish | Oct 10, 2022 | 4 years ago |
| SMA: Bearish | Oct 10, 2022 | 4 years ago |
| SMA: Bullish | Sep 26, 2022 | 4 years ago |
| SMA: Bullish | Sep 26, 2022 | 4 years ago |
| SMA: Bearish | Sep 19, 2022 | 4 years ago |
| SMA: Bullish | Sep 12, 2022 | 4 years ago |
| SMA: Bearish | Aug 15, 2022 | 4 years ago |
| SMA: Bearish | Aug 15, 2022 | 4 years ago |
| SMA: Bullish | Aug 8, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| SMA: Bearish | Jul 25, 2022 | 4 years ago |
| SMA: Bullish | Jul 4, 2022 | 4 years ago |
| SMA: Bearish | Jun 6, 2022 | 4 years ago |
| SMA: Bullish | May 30, 2022 | 4 years ago |
| MACD: Buy Signal | May 9, 2022 | 4 years ago |
| RSI: Oversold | Feb 28, 2022 | 4 years ago |
| SMA: Bearish | Dec 20, 2021 | 4 years ago |
| SMA: Bullish | Dec 13, 2021 | 4 years ago |
| SMA: Bearish | Nov 29, 2021 | 4 years ago |
| SMA: Bearish | Nov 22, 2021 | 4 years ago |
| RSI: Overbought | Oct 25, 2021 | 5 years ago |
| SMA: Bullish | Oct 11, 2021 | 5 years ago |
| SMA: Bearish | Oct 4, 2021 | 5 years ago |
| SMA: Bullish | Sep 13, 2021 | 5 years ago |
| RSI: Overbought | Sep 13, 2021 | 5 years ago |
| SMA: Bearish | Sep 6, 2021 | 5 years ago |
| RSI: Oversold | Sep 6, 2021 | 5 years ago |
| SMA: Bullish | Aug 2, 2021 | 5 years ago |
| SMA: Bearish | Jul 12, 2021 | 5 years ago |
| SMA: Bullish | Jun 28, 2021 | 5 years ago |
Key statistics
- Market cap
- 1.01B
- Enterprise value
- 933.60M
- Trailing P/E
- 0.00
- Forward P/E
- -5.17
- PEG ratio
- 0.00
- Price / sales
- 7.62
- Price / book
- 2.27
- EPS (TTM)
- -5.06
- Beta
- 1.79
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -219.61%
- Revenue (TTM)
- 132.42M
- Revenue growth
- -48.50%
- Free cash flow
- -72.40M
- Total cash
- 302.16M
- Total debt
- 404.11M
- Return on equity
- -59.94%
- Shares outstanding
- 55.38M
- Short % of float
- 13.36%
- 50-day average
- 8.08
- 200-day average
- 8.32
Analyst view
Consensus: none
Price target (mean) 7.00 -37.6% downside
Now 11.21
- Target (low)
- 5.00
- Target (mean)
- 7.00
- Target (high)
- 9.00
Ratings (0m) 3 0 buy · 1 hold · 2 sell
- Strong buy0
- Buy0
- Hold1
- Sell1
- Strong sell1
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate -0.58.
Financials — quick view
DNA Revenue — quarterly 20.16M
DNA Net income — quarterly -46.71M
DNA EPS — quarterly -0.75
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | -0.58 | — | — | — |
| Aug 5, 2026 | Jun 30, 2026 | -0.895 | -0.75 | +0.15 | +16.20% |
| May 7, 2026 | Mar 31, 2026 | -1.21 | -1.39 | -0.18 | -14.77% |
| Feb 26, 2026 | Dec 31, 2025 | -1.80 | -1.42 | +0.38 | +21.11% |
| Nov 6, 2025 | Sep 30, 2025 | -1.24 | -1.45 | -0.21 | -16.94% |
| Aug 7, 2025 | Jun 30, 2025 | -1.44 | -1.10 | +0.34 | +23.61% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 4, 2026 | BTIG | reit | Sell | Sell |
| Aug 7, 2026 | TD Cowen | down | Buy | Hold |
| Mar 12, 2026 | BTIG | main | Sell | Sell |
| Jan 8, 2026 | TD Cowen | main | Buy | Buy |
| Aug 25, 2025 | BTIG | main | Sell | Sell |
| Sep 20, 2024 | TD Cowen | main | Buy | Buy |
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- ginkgo.bio
News
- Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights
- Cathie Wood Is Buying Archer Aviation Stock. Here's What History Says About Following Ark Into a Stock Down 62%.
- Hugging Face is launching a new AI model that lets scientists 'chat with DNA'
- Cerenome Announces New Dual Mechanism of Action Featuring Lethal DNA Damage and Beneficial Immunomodulation Supporting Lead Investigational Drug REYOBIQ™
- Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know
- Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market
- TD Cowen Maintains Hold on Ginkgo Bioworks Holdings, Raises Price Target to $11
- Glaukos Reveals Superior Intraocular Pressure Reduction With Novel Eye Therapy
- What's Going on With Ginkgo Bioworks Stock on Friday?
- What's Going on With Ginkgo Bioworks Stock on Friday?
Your note
Sign in to keep a note on DNA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CANTON BARTHOLOMEW | Beneficial Owner of more than 10% of a Class of Security | Sale | Apr 9, 2026 | 0 |
| COEN STEVEN P. | Chief Financial Officer | Sale | Aug 23, 2026 | 51,851 |
| DMYTRUK MARK E | Chief Financial Officer | Sale | May 20, 2025 | 46,226 |
| HANNAN KATHY HOPINKAH | Director | Conversion of Exercise of derivative security | Jun 10, 2025 | 15,003 |
| HENRY CHRISTIAN O | Director | Sale | Sep 14, 2026 | 19,310 |
| KELLY JASON R | Chief Executive Officer | Sale | Apr 8, 2026 | 316,483 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 7.73% | 4,282,903 | 64.16M | Jun 29, 2026 |
| Viking Global Investors, L.P. | 6.46% | 3,577,128 | 53.59M | Jun 29, 2026 |
| Erste Asset Management GmbH | 4.58% | 2,536,939 | 38.00M | Jun 29, 2026 |
| BAILLIE GIFFORD & CO | 4.32% | 2,391,649 | 35.83M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 3.77% | 2,087,293 | 31.27M | Jun 29, 2026 |
| Anchorage Capital Group, LLC | 3.15% | 1,746,363 | 26.16M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.69% | 1,489,851 | 22.32M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.23% | 1,232,832 | 18.47M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.99% | 550,071 | 8.24M | Jun 29, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.94% | 523,147 | 7.84M | Jul 30, 2026 |
| PIMCO Equity Series-PIMCO RAE US Small Fund | 0.91% | 506,312 | 7.58M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 Value ETF | 0.80% | 441,778 | 6.62M | Aug 30, 2026 |